French drugmaker Sanofi (SNY) said that the U.S.
Shares in Translate Bio (TBIO) surged 24% on Friday, after Sanofi (SNYNF) made several positive comments about the outlook for their joint coronavirus …
The last decade, since the financial crisis of 2008 and the subsequent Great Recession, have seen a heavy dominance of US companies in …
Stock go up, investor happy. Stock go down, investor… sad?
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (NYSE:SNY) announced that the FDA approved DUPIXENT® (dupilumab) Injection, the first and only biologic medicine approved for …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the European Commission (EC) has granted marketing authorization for Praluent® (alirocumab) for the …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that, in a new pooled analysis of heterozygous familial hypercholesterolemia (HeFH) patients included in …
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) announces it has entered into a global license and supply agreement with Sanofi SA (ADR) (NYSE:SNY) to utilize Captisol in …
In a research report released Tuesday, Canaccord analyst John Newman reiterated a Buy rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a price target of …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR)(NYSE:SNY) have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments …
